Skip to main content

Blog

Avidity Biosciences Announces Positive Topline Del-zota Data in Phase 1/2 EXPLORE44® Trial

...

The Impact of the Continuing Resolution and Federal Budget Cuts to the CDMRP on Duchenne Research

...

PPMD Hosts Duchenne Early Intervention Symposium

...

Advocates Unite in Washington D.C. to Champion Duchenne Policy Reforms

...

Capricor Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application for Deramiocel

...

WATCH: Solid Biosciences – Update on Gene Therapy Candidate SGT-003 (Webinar Recording)

...

Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44

...

Solid Biosciences Shares Initial Data from INSPIRE DUCHENNE Study of Gene Therapy Candidate SGT-003

...

Cumberland Pharmaceuticals Announces Positive Results from Phase 2 FIGHT DMD Trial of Ifetroban for Treatment of Duchenne Cardiomyopathy

...

Sarepta Therapeutics Announces Results from Part 2 of EMBARK Study of ELEVIDYS

...